ArticleCost effectiveness and resource allocation : C/E2021
Economic burden of cardiovascular diseases before and after Iran's health transformation plan: evidence from a referral hospital of Iran.
Article in Cost effectiveness and resource allocation : C/E, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Predictive value of aortic propagation velocity for cardiovascular events in asymptomatic individuals with elevated ASCVD risk.Scientific reports · 2026Article
- Latent Class Analysis for Clustering Iranian Individuals Based on Cardiovascular Risk Factors.Medical journal of the Islamic Republic of Iran · 2026Article
- Economic drivers and systemic disparities in invasive coronary angiography: Insights from a national claims database.PloS one · 2026Article
- Article
- The effect of electronic video training and preangiography nursing education on anxiety and physiological parameters of patients undergoing coronary angiography.Journal of education and health promotion · 2025Article
- Economic burden of cardiovascular diseases among elderly patients in Iran: a case from a developing country.BMC health services research · 2024Article
- Promotion of nutritional behaviors in the prevention of cardiovascular diseases: application of the health belief model in primary health care centers.BMC primary care · 2023Article
- The Effect of Iran Health Transformation Plan on Equity in Health Financing: A Systematic Review.Iranian journal of public health · 2023Review
- Laboratory-based versus non-laboratory-based World Health Organization risk equations for assessment of cardiovascular disease risk.BMC medical research methodology · 2023Article
- Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran.The journal of Tehran Heart Center · 2023Article
- Ethnic differences in the lifestyle behaviors and premature coronary artery disease: a multi-center study.BMC cardiovascular disorders · 2023Article
- Article
- The effect of Iran's health sector evolution plan on hospitals performance indicators: an interrupted time series analysis.Frontiers in health services · 2023Article
- Heart failure: a prevalence-based and model-based cost analysis.Frontiers in cardiovascular medicine · 2023Article
- Decomposition of Socioeconomic Inequality in Cardiovascular Disease Prevalence in the Adult Population: A Cohort-based Cross-sectional Study in Northwest Iran.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2022Article
- The use and the cost of outpatient diagnostic procedures for cardiovascular diseases in Isfahan province: A utilization study.Journal of education and health promotion · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundDifferent countries have set different policies to control and decrease the costs of cardiovascular diseases (CVDs). Iran was aiming to reduce the economic burden of different disease by a recent reform from named as health transformation plan (HTP). This study aimed to examine the economic burden of CVDs before and after of HTP.
methodsThis cross-sectional study was conducted on 600 patients with CVDs, who were randomly selected from a specialized cardiovascular hospital in the north-west of Iran. Direct and indirect costs of CVDs were calculated using the cost of illness and human capital approaches. Data were collected using a researcher-made checklist obtained from several sources including structured interviews, the Statistical Center of Iran, Iran's Ministry of Cooperatives, Labor, and Social Welfare, the central bank of Iran, and the data of global burden of disease obtained from the Institute for Health Metrics and Evaluation to estimate direct and mortality costs. All costs were calculated in Iranian Rials (IRR).
resultsTotal costs of CVDs were about 5571 and 6700 billion IRR before and after the HTP, respectively. More than 62% of the total costs of CVDs accounted for premature death before (64.89%) and after (62.01%) the HTP. The total hospitalization costs of CVDs was significantly increased after the HTP (p = 0.038). In both times, surgical services and visiting had the highest and lowest share of hospitalization costs, respectively. The OOP expenditure decreased significantly and reached from 54.2 to 36.7%. All hospitalization costs, except patients' OOP expenditure, were significantly increased after the HTP about 1.3 times. Direct non-medical costs reached from 2.4 to 3.3 billion before and after the HTP, respectively.
conclusionEconomic burden of CVDs increased in the north-west of Iran after the HTP due to the increase of all direct and indirect costs, except the OOP expenditure. Non-allocation of defined resources, which coincided with the international and national political and economic challenges in Iran, led to unsustainable resources of the HTP. So, no results of this study can be attributed solely to the HTP. Therefore, more detailed studies should be carried out on the reasons for the significant increase in CVDs costs in the region.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.